Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.36 |
| ▸ | DRD2 | P14416 | 6/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.33 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.33 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.33 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.33 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.33 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.33 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31269173 | 0.94 | PDE2A (0.37) | PDE2AHRH4DRD2TLR7KDM4E | |
| SCHEMBL30983378 | 0.91 | HTR6 (0.41) | PDE2AHRH4DRD2TLR7KDM4E | |
| SCHEMBL30983795 | 0.91 | PDE2A (0.42) | PDE2AHRH4DRD2TLR7KDM4E | |
| SCHEMBL30983407 | 0.88 | PDE2A (0.38) | PDE2AHRH4DRD2KDM4EALDH1A1 | |
| SCHEMBL31269041 | 0.88 | PDE2A (0.38) | PDE2AHRH4DRD2TLR7KDM4E | |
| SCHEMBL31268993 | 0.88 | PDE2A (0.38) | PDE2AHRH4DRD2TLR7KDM4E | |
| SCHEMBL30984056 | 0.88 | PDE2A (0.42) | PDE2AHRH4DRD2KDM4EALDH1A1 | |
| SCHEMBL30984054 | 0.88 | PDE2A (0.42) | PDE2AHRH4DRD2KDM4EALDH1A1 | |
| SCHEMBL30983443 | 0.87 | PDE2A (0.38) | PDE2AHRH4DRD2KDM4EALDH1A1 | |
| SCHEMBL30983420 | 0.87 | HRH4 (0.41) | PDE2AHRH4DRD2TLR7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |